GELBMAN RONALD G

Average Profitability
4.67%
Insider Buys Quantity
1
Insider Buys Sum
$399,734.84
Insider Sells Quantity
16
Insider Sells Sum
$9.8M

Insider Activity of GELBMAN RONALD G

The largest purchase of all time was on 2006-08-02 and amounted to 8884 shares of Haemonetics Corporation for $399,735.

The largest sale of all time was on 2019-11-11 and amounted to 16926 shares of Haemonetics Corporation for $2M.

Biography of GELBMAN RONALD G

No biography is available at this moment.

2019-11-11SaleHaemonetics Corporation
HAE
director
16,926
0.0333%
$118.26$2M-14.68%
2019-08-08SaleHaemonetics Corporation
HAE
director
1,696
0.0033%
$134.15$227,518-14.37%
2019-02-15SaleHaemonetics Corporation
HAE
director
8,196
0.0156%
$86.52$709,118+34.08%
2018-12-14SaleHaemonetics Corporation
HAE
director
4,329
0.0084%
$103.02$445,974+10.87%
2017-11-16SaleHaemonetics Corporation
HAE
director
5,440
0.0101%
$56.69$308,404+55.77%
2017-03-24SaleHaemonetics Corporation
HAE
director
8,580
0.0168%
$40.00$343,200+9.24%
2016-12-12SaleHaemonetics Corporation
HAE
director
5,683
0.011%
$40.30$229,025+1.56%
2015-03-05SaleHaemonetics Corporation
HAE
director
7,707
0.015%
$44.76$344,936-19.22%
2014-06-12SaleHaemonetics Corporation
HAE
director
18,368
0.0308%
$29.48$541,514+9.7%
2014-03-06SaleHaemonetics Corporation
HAE
director
24,000
0.0317%
$24.61$590,645-0.53%
2012-12-13SaleHaemonetics Corporation
HAE
director
22,620
0.0443%
$40.07$906,404+3.87%
2012-08-23SaleHaemonetics Corporation
HAE
director
12,000
0.0376%
$58.32$699,840+12.94%
2012-05-17SaleHaemonetics Corporation
HAE
director
4,946
0.0196%
$71.49$353,590+12.95%
2010-12-23SaleHaemonetics Corporation
HAE
director
12,000
0.036%
$48.12$577,407-4.64%
2010-05-11SaleHaemonetics Corporation
HAE
director
18,000
0.0713%
$57.02$1.03M+1.69%
2009-09-18SaleHaemonetics Corporation
HAE
director
12,000
0.0349%
$41.56$498,760-1.29%
2006-08-02PurchaseHaemonetics Corporation
HAE
director
8,884
0.0328%
$44.99$399,735+4.67%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.